AC Immune (ACIU) Operating Leases (2017 - 2026)

AC Immune (ACIU) has reported Operating Leases for 9 consecutive years, with $4.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Leases rose 96334.89% year-over-year to $4.4 billion; the TTM figure through Mar 2026 stood at $4.4 billion (up 96334.89% YoY), while the FY2025 annual figure was $4.4 billion, up 88465.92% from the prior year.
• Operating Leases declined to $4.4 billion in Q1 2026 per ACIU's latest filing, from $4.6 billion in the prior quarter.
• Across five years, Operating Leases topped out at $4.6 billion in Q4 2025 and bottomed at $2.0 million in Q3 2022.
• Historically, Operating Leases has averaged $987.5 million across 5 years, with a median of $4.5 million in 2025.
• Annual changes were most pronounced in 2022 — Operating Leases plunged 99.91% — and 2023, when it jumped 136079.34%.
• AC Immune's Operating Leases stood at $2.3 million in 2022, then soared by 136079.34% to $3.2 billion in 2023, then tumbled by 99.84% to $5.0 million in 2024, then soared by 91773.3% to $4.6 billion in 2025, then declined by 3.75% to $4.4 billion in 2026.
• Business Quant data shows ACIU's Operating Leases at $4.4 billion in Q1 2026, $4.6 billion in Q4 2025, and $4.5 million in Q3 2025.